We're excited to share that the Mass General Brigham Research Spotlight features CSB (Weissleder Lab and Garris Lab) paper published in Nature Biotechnology, “Immune-remodeling mRNAs expressing IRF8 or NIK generate durable antitumor immunity in multiple cancer models."